Abstract

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong ... Lingli Dong
The Lancet Rheumatology | VOL. 2
Jixin Zhong, et. al.Jixin Zhong ... Lingli Dong
20 May 2020
The role of antirheumatics in patients with COVID-19
Christoffer B Nissen ... Mattia Trunfio
The Lancet Rheumatology | VOL. 3
Christoffer B Nissen, et. al.Christoffer B Nissen ... Mattia Trunfio
30 Mar 2021
A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
Dennis Mcgonagle ... James F M Meaney
The Lancet Respiratory Medicine | VOL. 9
Dennis Mcgonagle, et. al.Dennis Mcgonagle ... James F M Meaney
14 May 2021
COVID-19 vasculitis and novel vasculitis mimics.
Dennis Mcgonagle ... Athimalaipet V Ramanan
The Lancet Rheumatology | VOL. 3
Dennis Mcgonagle, et. al.Dennis Mcgonagle ... Athimalaipet V Ramanan
07 Jan 2021
View more papers

More From: The Lancet

Paper Title
Journal
Date
Author
Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis
I Sermet-Gaudelus ... Nathalie Wizla
The Lancet | VOL. -
I Sermet-Gaudelus, et. al.I Sermet-Gaudelus ... Nathalie Wizla
28 Jun 2024
How effective is transcranial direct current stimulation? – Authors' reply
Gerrit Burkhardt ... Frank Padberg
The Lancet | VOL. 403
Gerrit Burkhardt, et. al.Gerrit Burkhardt ... Frank Padberg
22 Jun 2024
Lung cancer treatment: 20 years of progress
The Lancet
The Lancet | VOL. 403
The Lancet The Lancet
22 Jun 2024
Department of Error
-
The Lancet | VOL. 403
--
22 Jun 2024
View more papers